Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge

Cancer Research and Treatment - South Korea
doi 10.4143/crt.2014.259
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Cancer Association

Related search

Hypofractionated Stereotactic Re-Irradiation: Treatment Option in Recurrent Malignant Glioma

BMC Cancer
Cancer ResearchOncologyGenetics
2005English

Hypofractionated Stereotactic Radiation Therapy/ Radiosurgery Results in Patients With Uveal Melanoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Timing of Surgery and Bevacizumab Therapy in Neurosurgical Patients With Recurrent High Grade Glioma

Journal of Clinical Neuroscience
MedicineSurgeryNeurologyPhysiology
2015English

Hypofractionated Stereotactic Body Radiation Therapy as Monotherapy for Intermediate-Risk Prostate Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2013English

Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas

2012English

Antiangiogenic Therapy Using Bevacizumab in Recurrent High-Grade Glioma: Impact on Local Control and Patient Survival

Journal of Neurosurgery
SurgeryNeurology
2009English

Echo-Planar MR Spectroscopic Imaging Pre and Post Radiation Therapy in Patients With High Grade Glioma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Dose-Intensified Hypofractionated Stereotactic Body Radiation Therapy for Painful Spinal Metastases: Results of a Phase 2 Study

Cancer
Cancer ResearchOncology
2018English

Re-Irradiation of Recurrent Glioblastoma Multiforme Using 11c-Methionine PET/CT/MRI Image Fusion for Hypofractionated Stereotactic Radiotherapy by Intensity Modulated Radiation Therapy

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy